These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

360 related items for PubMed ID: 26923035

  • 1. Effects of Modafinil and Armodafinil in Patients With Obstructive Sleep Apnea: A Meta-analysis of Randomized Controlled Trials.
    Kuan YC, Wu D, Huang KW, Chi NF, Hu CJ, Chung CC, Tam KW, Huang YH.
    Clin Ther; 2016 Apr; 38(4):874-88. PubMed ID: 26923035
    [Abstract] [Full Text] [Related]

  • 2. Effect of Wakefulness-Promoting Agents on Sleepiness in Patients with Sleep Apnea Treated with CPAP: A Meta-Analysis.
    Sukhal S, Khalid M, Tulaimat A.
    J Clin Sleep Med; 2015 Oct 15; 11(10):1179-86. PubMed ID: 25979103
    [Abstract] [Full Text] [Related]

  • 3. Modafinil/armodafinil in obstructive sleep apnoea: a systematic review and meta-analysis.
    Chapman JL, Vakulin A, Hedner J, Yee BJ, Marshall NS.
    Eur Respir J; 2016 May 15; 47(5):1420-8. PubMed ID: 26846828
    [Abstract] [Full Text] [Related]

  • 4. Indirect treatment comparison of solriamfetol, modafinil, and armodafinil for excessive daytime sleepiness in obstructive sleep apnea.
    Ronnebaum S, Bron M, Patel D, Menno D, Bujanover S, Kratochvil D, Lucas E, Stepnowsky C.
    J Clin Sleep Med; 2021 Dec 01; 17(12):2543-2555. PubMed ID: 34402784
    [Abstract] [Full Text] [Related]

  • 5. Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndrome.
    Hirshkowitz M, Black JE, Wesnes K, Niebler G, Arora S, Roth T.
    Respir Med; 2007 Mar 01; 101(3):616-27. PubMed ID: 16908126
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of adjunctive modafinil treatment on residual excessive daytime sleepiness among nasal continuous positive airway pressure-treated japanese patients with obstructive sleep apnea syndrome: a double-blind placebo-controlled study.
    Inoue Y, Takasaki Y, Yamashiro Y.
    J Clin Sleep Med; 2013 Aug 15; 9(8):751-7. PubMed ID: 23946704
    [Abstract] [Full Text] [Related]

  • 7. Findings of the Maintenance of Wakefulness Test and its relationship with response to modafinil therapy for residual excessive daytime sleepiness in obstructive sleep apnea patients adequately treated with nasal continuous positive airway pressure.
    Inoue Y, Miki M, Tabata T.
    Sleep Med; 2016 Aug 15; 27-28():45-48. PubMed ID: 27938918
    [Abstract] [Full Text] [Related]

  • 8. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.
    Roth T, White D, Schmidt-Nowara W, Wesnes KA, Niebler G, Arora S, Black J.
    Clin Ther; 2006 May 15; 28(5):689-706. PubMed ID: 16861091
    [Abstract] [Full Text] [Related]

  • 9. Armodafinil improves wakefulness and long-term episodic memory in nCPAP-adherent patients with excessive sleepiness associated with obstructive sleep apnea.
    Roth T, Rippon GA, Arora S.
    Sleep Breath; 2008 Mar 15; 12(1):53-62. PubMed ID: 17874255
    [Abstract] [Full Text] [Related]

  • 10. Effect of armodafinil on cortical activity and working memory in patients with residual excessive sleepiness associated with CPAP-Treated OSA: a multicenter fMRI study.
    Greve DN, Duntley SP, Larson-Prior L, Krystal AD, Diaz MT, Drummond SP, Thein SG, Kushida CA, Yang R, Thomas RJ.
    J Clin Sleep Med; 2014 Feb 15; 10(2):143-53. PubMed ID: 24532997
    [Abstract] [Full Text] [Related]

  • 11. Effects of armodafinil on simulated driving and self-report measures in obstructive sleep apnea patients prior to treatment with continuous positive airway pressure.
    Kay GG, Feldman N.
    J Clin Sleep Med; 2013 May 15; 9(5):445-54. PubMed ID: 23674935
    [Abstract] [Full Text] [Related]

  • 12. Tolerability and efficacy of armodafinil in naïve patients with excessive sleepiness associated with obstructive sleep apnea, shift work disorder, or narcolepsy: a 12-month, open-label, flexible-dose study with an extension period.
    Schwartz JR, Khan A, McCall WV, Weintraub J, Tiller J.
    J Clin Sleep Med; 2010 Oct 15; 6(5):450-7. PubMed ID: 20957845
    [Abstract] [Full Text] [Related]

  • 13. A double-blind, placebo-controlled study of armodafinil for excessive sleepiness in patients with treated obstructive sleep apnea and comorbid depression.
    Krystal AD, Harsh JR, Yang R, Rippon GA, Lankford DA.
    J Clin Psychiatry; 2010 Jan 15; 71(1):32-40. PubMed ID: 20051221
    [Abstract] [Full Text] [Related]

  • 14. Modafinil improves daytime sleepiness in patients with mild to moderate obstructive sleep apnoea not using standard treatments: a randomised placebo-controlled crossover trial.
    Chapman JL, Kempler L, Chang CL, Williams SC, Sivam S, Wong KK, Yee BJ, Grunstein RR, Marshall NS.
    Thorax; 2014 Mar 15; 69(3):274-9. PubMed ID: 24287166
    [Abstract] [Full Text] [Related]

  • 15. Pharmacological interventions for sleepiness and sleep disturbances caused by shift work.
    Liira J, Verbeek JH, Costa G, Driscoll TR, Sallinen M, Isotalo LK, Ruotsalainen JH.
    Cochrane Database Syst Rev; 2014 Aug 12; 2014(8):CD009776. PubMed ID: 25113164
    [Abstract] [Full Text] [Related]

  • 16. Modafinil for treatment of residual excessive sleepiness in nasal continuous positive airway pressure-treated obstructive sleep apnea/hypopnea syndrome.
    Black JE, Hirshkowitz M.
    Sleep; 2005 Apr 12; 28(4):464-71. PubMed ID: 16171291
    [Abstract] [Full Text] [Related]

  • 17. Armodafinil.
    Garnock-Jones KP, Dhillon S, Scott LJ.
    CNS Drugs; 2009 Sep 12; 23(9):793-803. PubMed ID: 19689169
    [Abstract] [Full Text] [Related]

  • 18. Residual Daytime Sleepiness in Obstructive Sleep Apnea After Continuous Positive Airway Pressure Optimization: Causes and Management.
    Chapman JL, Serinel Y, Marshall NS, Grunstein RR.
    Sleep Med Clin; 2016 Sep 12; 11(3):353-63. PubMed ID: 27542881
    [Abstract] [Full Text] [Related]

  • 19. Armodafinil for excessive daytime sleepiness.
    Nishino S, Okuro M.
    Drugs Today (Barc); 2008 Jun 12; 44(6):395-414. PubMed ID: 18596995
    [Abstract] [Full Text] [Related]

  • 20. The long-term tolerability and efficacy of armodafinil in patients with excessive sleepiness associated with treated obstructive sleep apnea, shift work disorder, or narcolepsy: an open-label extension study.
    Black JE, Hull SG, Tiller J, Yang R, Harsh JR.
    J Clin Sleep Med; 2010 Oct 15; 6(5):458-66. PubMed ID: 20957846
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.